Treating Blood Cancers

Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ

Recorded on August 13, 2026

Ramy Sedhom, MD, FASCO

Associate Professor, Clinical Medicine, Division of Hematology/Oncology

Director, Program in Geriatric Oncology & Supportive Care Innovation and the

Center for Cancer and Aging at the Penn Center for Cancer Care Innovation

University of Pennsylvania

Plainsboro, NJ

In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation!

Mentioned on this episode:

The Journal of Palliative Medicine: Top Ten Tips on Bereavement Care

Man’s Search for Meaning by Viktor E. Frankl

It’s OK That You’re Not OK by Megan Devine

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN

Recorded on June 23, 2026

Stephen Ansell, MD, PhD

Division Chair, Hematology

Mayo Clinic

Rochester, MN

Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Recorded on June 2, 2026

Marina Kremyanskaya, MD, PhD

Associate Professor

Tisch Cancer Institute

Icahn School of Medicine at Mount Sinai

New York, NY

Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care.
Don’t miss this informative episode!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Recorded on May 28, 2026

Tara Gregory, MD

President

Colorado Blood Cancer Institute

Denver, CO

Jay Spiegel, MD

Assistant Professor

Division of Transplant and Cellular Therapy

University of Miami Sylvester Comprehensive Cancer Center

Miami, FL

In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode!

Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients

This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company.

Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA

Recorded on May 12, 2026

Lori Muffly, MD, MS

Professor of Medicine

Division of Blood and Marrow Transplantation & Cellular Therapy

Stanford Medicine

Stanford, CA

In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next.

Mentioned on this episode:

www.NMDP.org

www.hematology.org

Additional Blood Cancer United Resources:

Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education

Blood Cancer United Resources for Patients